The linearly decreasing convergence factor a. by Junhao Wei (6816803)

Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

“…In contrast, s-ketamine appeared to produce a smaller decrease in VTV (ß = −0.062, 95% CI: −0.118 to −0.003) with VRR remaining unaffected (ß = −0.036, 95% CI: −0.092 to 0.019). …”

Naringenin decreases mitochondrial function. by Lauren A. Eanes (20995499)

Table1_Leukocyte telomere length decreased the risk of mortality in patients with alcohol-associated liver disease.docx by Jiahong Yi (14481735)

“…LTL might be a useful biomarker for prognosis among patients with ALD. …”

Naringenin decreases total cell viability. by Lauren A. Eanes (20995499)

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

Linear regression analysis. by Young Kyu Lee (14076058)

Subjects:

Why does task performance decrease with burst length? by Swathi Anil (17382903)

“…See <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1013125#pcbi.1013125.s001" target="_blank">S1 Appendix</a>.…”

Experimental validation revealed that ACADSB and ACADM decreased in patients with UC. by Hongliang Chen (538815)

Distribution of Patient-centered care scores as a function of Time. by Thales Guardia de Barros (22216025)

Subjects:

Boxplot of Patient-centered care scores as a function of Time. by Thales Guardia de Barros (22216025)

Subjects:

Changes in baseline T-cell activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

DYRK1A activity on HBV transcription regulatory regions. by Florentin Pastor (19852287)

Subjects:

Changes in baseline T-cell exhaustion, monocyte activation and platelet activation markers through week 12 and week 24 according to the linear regression model. a. by Tosi M. Mwakyandile (16408705)

Comparison of serum VEGF-A165 concentrations pre-bevacizumab administration in patients with increased VEGF-A post-bevacizumab administration and those with decreased VEGF-A. by Masashi Okawa (8951294)

Subjects:

Patient characteristics. by Jonathan S. Jahr (2709088)

Subjects:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness. by Gui Araujo (22170819)

“…(C) Mutualism also promotes an increase in network connectance when introduced into assembled communities, while stopping mutualistic interactions from entering an assembled system slowly decreases it. (D) As a result, the introduction of mutualistic interactions promotes a growth in complexity in communities where it was once established as low, while stopping the introduction of further mutualistic interactions causes a slight decrease in complexity. …”

K1 expression decreases in HA15 treated cells. by Guillermo Najarro (19964572)

Knock-down of DYRK1A decreases HBV RNAs levels in HBV-infected dHepaRG cells. by Florentin Pastor (19852287)

Subjects: